Espenal

Espenal

eperisone

Manufacturer:

Sriprasit Pharma

Distributor:

SPS Medical
Concise Prescribing Info
Contents
Eperisone HCl
Indications/Uses
Spastic paralysis in cerebrovascular disease, spastic spinal paralysis, cervical spondylosis, post-op sequelae (including cerebrovascular tumor), sequelae to trauma (eg, spinal trauma, head injury), amyotrophic lateral sclerosis, cerebral palsy, spinocerebellar degeneration, spinal vascular diseases & other encephalomyelopathies. Improvement of muscular hypertonic symptoms in conditions eg, cervical syndrome, periarthritis of the shoulder, lumbago.
Dosage/Direction for Use
Adult 50-150 mg/day in divided doses.
Administration
Should be taken with food.
Special Precautions
Liver function disorders. May impair ability to drive or operate machinery. Childn. Pregnancy & lactation.
Adverse Reactions
Shock & anaphylactoid reactions, Stevens-Johnson syndrome & toxic epidermal necrosis (discontinue use). Anaemia, rash, pruritus, sleepiness, insomnia, headache, nausea & vomiting, anorexia, abdominal pain, diarrhoea, constipation, urinary retention or incontinence.
Drug Interactions
Tolperisone HCl, methocarbamol.
MIMS Class
ATC Classification
M03BX09 - eperisone ; Belongs to the class of other centrally-acting muscle relaxants.
Presentation/Packing
Form
Espenal film-coated tab 50 mg
Packing/Price
10 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in